Peptide website compliance checklist for processors
- Underwriters open your peptide website and read it before they approve you. The site, not the application, is what gets most operators declined.
- The non-negotiables: research-use labeling without human-dosing language, a visible refund policy, an FDA disclaimer where claims appear, and reachable contact info.
- Fix the website before you apply. A decline costs you an application footprint; a clean site costs you an afternoon.
On this page
An underwriter has your application open in one tab and your storefront open in another. They are not reading your form anymore. They are clicking through your product pages, reading your refund policy, looking for a disclaimer, and trying to find a way to contact you as if they were a customer. In the next ten minutes, what is on your website decides whether you get approved. Your bank statements got you in the room; your website is what keeps you there.
This is the checklist underwriters actually work from when they review a peptide store. It is not legal advice, and you should run anything ambiguous past a regulatory attorney. But every item here is something a real reviewer checks, and every one of them has declined real operators. Treat it as a pre-application audit you run on your own store before anyone else does.
Why the website matters more than the application
Peptide underwriting is not just a numbers exercise. Aggregators like Stripe decline peptides outright; specialist acquirers approve them but price the risk, and a sloppy website is the clearest risk signal there is. A store that reads like it is selling consumption products to humans, with no disclaimers and no way to reach support, tells the underwriter exactly how the chargebacks will arrive. A clean store tells the opposite story. The site is the cheapest lever you control. We cover the full review in what acquirers actually check.
The labeling check
This is where most declines start. Underwriters read your product pages for human-consumption language.
- Products framed for research use, consistently, on every product page, not just the homepage.
- No human-dosing instructions. "Take X mg daily" on a product page is the single fastest decline trigger.
- No therapeutic or disease claims. "Treats," "cures," and "for weight loss" turn a research product into an unapproved drug claim in the reviewer's eyes.
- SARMs and research-chem SKUs labeled with the same discipline as peptides; mixed framing across a catalog reads as inconsistent.
Consistency is the tell. One compliant product page and four sloppy ones reads worse than five mediocre-but-consistent ones, because it suggests the compliant page was for show.
The disclaimer check
Where any health-adjacent claim appears, the reviewer expects a disclaimer near it.
- An "FDA has not evaluated these statements" line where supplement-style claims appear.
- A research-use disclaimer where applicable, visible and not buried.
- Disclaimers placed near the claim, not hidden only in a footer link the reviewer has to dig for.
A missing disclaimer is not just a compliance gap; to an underwriter it signals an operator who has not thought about regulatory exposure, which is the same operator who will generate disputes.
The refund and policy check
Your refund policy is read as a chargeback predictor. "All sales final" with no exceptions is a red flag, because customers who cannot get a refund file a dispute instead, which drives your chargeback ratio straight at the network thresholds. Visa flags excessive at 0.9% and Mastercard at 1.0%, and your refund policy is one of the levers that keeps you under them.
- A specific, visible refund and return policy linked from the footer and the checkout.
- Clear shipping and delivery terms, since "never arrived" is a common dispute reason.
- Terms of service and a privacy policy present and current.
- A refund path that gives a frustrated customer somewhere to go besides their bank.
A better refund policy is one of the cheapest ways to cut disputes; we walk through it in cut peptide chargebacks with a better refund policy.
The contact and trust check
The reviewer tries to contact you as a customer would. If they cannot find a real channel, that is a flight-risk signal.
- A working support email or ticket system, not only a bare contact form.
- A business name and address consistent with your application and your billing descriptor.
- A descriptor a customer will actually recognize on their statement, so they call you before they call their bank.
- An about page that makes the business look like a business.
The COA and product-evidence check
Certificate-of-analysis availability signals a legitimate operator. You do not need to fabricate lab data, and you should never invent it. If you do not host COA PDFs, a per-product "request COA" link to a real inbox is an acceptable and honest path. What underwriters do not want to see is a COA download button that leads nowhere, which reads as worse than having none at all.
The age and consent check
Depending on your products and claims, reviewers may look for an age gate and a consent acknowledgment at checkout. Where it applies, an age-verification step and a research-use acknowledgment the customer actively confirms both strengthen the file. Do not bolt on an age gate that silently breaks your checkout; a modal that blocks the buy button hurts conversion and helps nobody.
The pre-application audit
Before you submit anything, walk your own store as if you were the underwriter. Use this as the final pass.
| Area | Pass condition | Common fail |
|---|---|---|
| Labeling | Research-use, no human dosing | "Take X mg daily" |
| Claims | No disease/therapeutic claims | "For weight loss" |
| Disclaimer | FDA line near claims | Missing or footer-only |
| Refund policy | Specific, visible | "All sales final" |
| Contact | Real reachable channel | Bare contact form |
| COA | Real PDFs or request link | Dead download button |
| Descriptor | Recognizable to customer | Cryptic or mismatched |
Fix every fail before you apply. A decline burns an application footprint and an underwriting impression; an afternoon of edits is free. If you run multiple brands, run this audit on every store, because a portfolio is reviewed as a portfolio and one weak site drags the whole file. See the peptide operator playbook for the multi-brand version.
What underwriters do not expect
It helps to know where the line is, because over-engineering compliance can hurt you too. Underwriters are not expecting you to be FDA-approved, to host a research lab, or to have a legal team. They are not asking you to remove your products. They are checking that the business presents itself honestly: research-use framing, real disclaimers, a refund path, reachable support, and a descriptor a customer recognizes. The goal is a store that does not generate disputes and does not misrepresent what it sells. Clean and honest beats elaborate and inconsistent every time, and an operator who clearly thought about exposure reads as lower-risk than one who papered the site with boilerplate.
Where this fits in your stack
This checklist is the same whether you process through a single specialist ISO or through a parent merchant account. multiflow does not onboard single-brand operators, and we do not process the payment ourselves; we are the orchestration layer on top of your acquirer, and the how it works page shows exactly where that layer sits. But every brand we touch still has to pass exactly this review, because the underwriter reads every site regardless of how the payments are organized. Compliance is upstream of the payment stack, not part of it.
If you run three or more peptide brands and want a read on whether your stores are application-ready across the portfolio, run the 12-question application for an honest fit check. We will flag the compliance gaps we see and tell you whether a specialist ISO or a parent account is the better path. No hard pull, no hard sell.